Mark R. Bamforth
InvestorExecutive Advisor at Ampersand
About
Mark R. Bamforth joined Ampersand as an Operating Partner in 2018 and became an Executive Advisor in 2023. He founded several contract development and manufacturing organizations, including Brammer Bio (cell and gene therapy, sold to Thermo Fisher Scientific in 2019), Arranta Bio (mRNA, sold to Recipharm), and Gallus BioPharmaceuticals (sold to DPx Holdings/Patheon in 2014), and earlier spent 22 years at Genzyme Corp. running global operations and its pharmaceutical CMO business. He holds a B.S. in Chemical Engineering from Strathclyde University and an M.B.A. from Henley Management College.
Invests in
Biotech
Investments
Board seats
Arranta BioCONTINUUS PharmaceuticalsEnteroBiotixKincell BioPneumagen Limited
Investor
Brammer Bio
Per the firm's website.
Colleagues at Ampersand
Aditya V. Goel
Associate at Ampersand
Benoit P. Bouche
Operating Partner at Ampersand
Cole S. Aldrich
Senior Associate at Ampersand
David Q. Anderson
General Partner at Ampersand
Dean D. Schauer
Operating Partner at Ampersand
Elias J. Laimboeck
Senior Associate at Ampersand
Emanuele M. Delfino
Associate at Ampersand
Eric B. Lev
General Partner at Ampersand
Frequently asked questions
- Who is Mark R. Bamforth?
- Mark R. Bamforth joined Ampersand as an Operating Partner in 2018 and became an Executive Advisor in 2023. He founded several contract development and manufacturing organizations, including Brammer Bio (cell and gene therapy, sold to Thermo Fisher Scientific in 2019), Arranta Bio (mRNA, sold to Recipharm), and Gallus BioPharmaceuticals (sold to DPx Holdings/Patheon in 2014), and earlier spent 22 years at Genzyme Corp. running global operations and its pharmaceutical CMO business. He holds a B.S. in Chemical Engineering from Strathclyde University and an M.B.A. from Henley Management College.
- Where does Mark R. Bamforth work?
- Mark R. Bamforth is Executive Advisor at Ampersand.
- What does Mark R. Bamforth invest in?
- Mark R. Bamforth invests in Biotech.
- What boards does Mark R. Bamforth sit on?
- Mark R. Bamforth holds tracked board seats at Arranta Bio, CONTINUUS Pharmaceuticals, EnteroBiotix, Kincell Bio, Pneumagen Limited.
- What companies has Mark R. Bamforth invested in?
- Investments tracked here include Brammer Bio.